Response to the Letter to the Editor: Prospective comparison of 18F-PSMA-1007 PET/CT, whole-body MRI and CT in primary nodal staging of unfavourable intermediate- and high-risk prostate cancer
Sign Up to like & getrecommendations! Published in 2021 at "European Journal of Nuclear Medicine and Molecular Imaging"
DOI: 10.1007/s00259-021-05428-7
Abstract: We thank Dr. Campaña and Dr. Bernal for their interest in our recent study about the prospective comparison of 18F-PSMA-1007 PET/CT, whole-body MRI with diffusionweighted imaging (DWI) and contrast-enhanced CT in primary nodal staging of… read more here.
Keywords: psma; 18f psma; prostate cancer; psma 1007 ... See more keywords
Preclinical Evaluation of a Companion Diagnostic Radiopharmaceutical, [18F]PSMA-1007, in a Subcutaneous Prostate Cancer Xenograft Mouse Model
Sign Up to like & getrecommendations! Published in 2022 at "Molecular Pharmaceutics"
DOI: 10.1021/acs.molpharmaceut.2c00788
Abstract: Several radiolabeled prostate-specific membrane antigen (PSMA)-targeted agents have been developed for detecting prostate cancer, using positron emission tomography imaging and targeted radionuclide therapy. Among them, [18F]PSMA-1007 has several advantages, including a comparatively long half-life, delayed… read more here.
Keywords: prostate cancer; psma; psma 1007; 18f psma ... See more keywords
Prospective intraindividual comparison of 18F-PSMA-7Q and 18F-DCFPyL PET/CT in patients with newly diagnosed prostate cancer.
Sign Up to like & getrecommendations! Published in 2022 at "Nuclear medicine communications"
DOI: 10.1097/mnm.0000000000001564
Abstract: OBJECTIVE Fluorine 18 (18F)-2-(3-{1-Carboxy-5-[(6-[(18)F]fluoro-pyridine-3-carbonyl)-amino]-pentyl}-ureido)-pentanedioic acid (DCFPyL) is an early 18F-labeled prostate-specific membrane antigen (PSMA) targeted PET tracer that has shown promise in the diagnostic workup of prostate cancer and was recently approved by the US… read more here.
Keywords: 18f psma; prostate cancer; psma; 18f dcfpyl ... See more keywords
Indeterminate skeletal and lymph node lesion on 18F PSMA 1007 PET/CT scanning: lessons from a review at 12 months with PSMA-RADS
Sign Up to like & getrecommendations! Published in 2022 at "Nuclear Medicine Communications"
DOI: 10.1097/mnm.0000000000001600
Abstract: Aims of the study The study utilizes the prostate-specific membrane antigen-reporting and data system (PSMA-RADS) version 1.0 in a real-world patient scenario in the evaluation of equivocal lesions using the PSMA-RADS categorization for patient management… read more here.
Keywords: psma rads; pet; lesion; psma ... See more keywords
Increased Uptake of 18F-PSMA-1007 in Corpus Luteum Demonstrated by PET/CT.
Sign Up to like & getrecommendations! Published in 2022 at "Clinical nuclear medicine"
DOI: 10.1097/rlu.0000000000004013
Abstract: ABSTRACT Two women were referred for an 18F-PSMA-1007 PET/CT in follow-up of an adenoid cystic tumor of the subglottic region and the bronchus, respectively. Only limited tracer uptake was seen in the region of local… read more here.
Keywords: psma 1007; 18f psma; pet; corpus luteum ... See more keywords
Comparison of Internal Dosimetry of 18F-PSMA-1007 and 68Ga-PSMA-11-HBED-CC
Sign Up to like & getrecommendations! Published in 2022 at "Clinical Nuclear Medicine"
DOI: 10.1097/rlu.0000000000004353
Abstract: Background Prostate cancer (PCa) is the most common cancer in men worldwide. Targeting prostate-specific membrane antigen (PSMA) using radiopharmaceuticals has shown promising results for PCa imaging as well as theranostics. 68Ga-based PSMA imaging is limited… read more here.
Keywords: mgy mbq; psma hbed; 68ga psma; psma ... See more keywords
Comparison of 18F-PSMA-1007 PET/CT With 68Ga-PSMA-11 PET/CT for Initial Staging in Intermediate- and High-Risk Prostate Cancer
Sign Up to like & getrecommendations! Published in 2022 at "Clinical Nuclear Medicine"
DOI: 10.1097/rlu.0000000000004430
Abstract: Purpose This study aimed to compare 18F-PSMA-1007 PET/CT with 68Ga-PSMA-11 PET/CT for initial staging in intermediate- and high-risk prostate cancer (PCa) patients. Methods Forty treatment-naive, biopsy-proven, intermediate- or high-risk PCa patients were prospectively recruited. Each… read more here.
Keywords: pet; 68ga psma; psma; 1007 pet ... See more keywords
Biokinetics and dosimetry of 18F‐PSMA‐1007 in patients with prostate cancer
Sign Up to like & getrecommendations! Published in 2022 at "Clinical Physiology and Functional Imaging"
DOI: 10.1111/cpf.12785
Abstract: Positron emission tomography‐computed tomography (PET‐CT) using prostate‐specific membrane antigen (PSMA) ligands is a method for imaging prostate cancer. A recent tracer, 18F‐PSMA‐1007, offers advantages concerning production and biokinetics compared to the standard tracer (68Ga‐PSMA‐11). Until… read more here.
Keywords: biokinetics dosimetry; prostate cancer; dosimetry 18f; psma 1007 ... See more keywords
Can 18F-PSMA-7Q PET/CT replace prostate biopsy for the diagnosis of prostate cancer?—A single-center retrospective study
Sign Up to like & getrecommendations! Published in 2023 at "Translational Andrology and Urology"
DOI: 10.21037/tau-22-813
Abstract: Background Of the currently available prostate-specific membrane antigen (PSMA) positron emission tomography (PET) tracers, although 68Ga-PSMA-11 and 18F-DCFPyL have been approved by the US Food and Drug Administration (FDA), both tracers are excreted rapidly through… read more here.
Keywords: 18f psma; prostate cancer; psma; psma pet ... See more keywords
Phase III Study of 18F-PSMA-1007 Versus 18F-Fluorocholine PET/CT for Localization of Prostate Cancer Biochemical Recurrence: A Prospective, Randomized, Crossover Multicenter Study
Sign Up to like & getrecommendations! Published in 2022 at "Journal of Nuclear Medicine"
DOI: 10.2967/jnumed.122.264743
Abstract: Visual Abstract The objective of this study was to compare 18F-PSMA-1007 PET/CT and 18F-fluorocholine PET/CT for the localization of prostate cancer (PCa) biochemical recurrence. Methods: This prospective, open-label, randomized, crossover multicenter study included PCa patients… read more here.
Keywords: psma 1007; 18f psma; pet; 18f fluorocholine ... See more keywords
Intra-Individual Comparison of 18F-PSMA-1007 and 18F-FDG PET/CT in the Evaluation of Patients With Prostate Cancer
Sign Up to like & getrecommendations! Published in 2020 at "Frontiers in Oncology"
DOI: 10.3389/fonc.2020.585213
Abstract: Purpose 18F labelled PSMA-1007 presents promising results in detecting prostate cancer (PC), while some pitfalls exists meanwhile. An intra-individual comparison of 18F-FDG and 18F-PSMA-1007 in patients with prostate cancer were aimed to be performed in… read more here.
Keywords: pet; psma 1007; 18f psma; suvmax suvmean ... See more keywords